<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30387004</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>09</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1573-7217</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                        <Day>01</Day>                    </PubDate>                </JournalIssue>                <Title>Breast cancer research and treatment</Title>                <ISOAbbreviation>Breast Cancer Res. Treat.</ISOAbbreviation>            </Journal>            <ArticleTitle>Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10549-018-5034-1</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">In post-menopausal women, high body mass index (BMI) is an established breast cancer risk factor and is associated with worse breast cancer prognosis. We assessed the associations between BMI and gene expression of both breast tumor and adjacent tissue in estrogen receptor-positive (ER+) and estrogen receptor-negative (ER-) diseases to help elucidate the mechanisms linking obesity with breast cancer biology in 519 post-menopausal women from the Nurses' Health Study (NHS) and NHSII.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Differential gene expression was analyzed separately in ER+ and ER- disease both comparing overweight (BMI ≥ 25 to &lt; 30) or obese (BMI ≥ 30) women to women with normal BMI (BMI &lt; 25), and per 5 kg/m<sup>2</sup> increase in BMI. Analyses controlled for age and year of diagnosis, physical activity, alcohol consumption, and hormone therapy use. Gene set enrichment analyses were performed and validated among a subset of post-menopausal cases in The Cancer Genome Atlas (for tumor) and Polish Breast Cancer Study (for tumor-adjacent).</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">No gene was differentially expressed by BMI (FDR &lt; 0.05). BMI was significantly associated with increased cellular proliferation pathways, particularly in ER+ tumors, and increased inflammation pathways in ER- tumor and ER- tumor-adjacent tissues (FDR &lt; 0.05). High BMI was associated with upregulation of genes involved in epithelial-mesenchymal transition in ER+ tumor-adjacent tissues.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study provides insights into molecular mechanisms of BMI influencing post-menopausal breast cancer biology. Tumor and tumor-adjacent tissues provide independent information about potential mechanisms.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Heng</LastName>                    <ForeName>Yujing J</ForeName>                    <Initials>YJ</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8930-817X</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Dana 517B, Boston, MA, 02215, USA. yheng@bidmc.harvard.edu.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Cancer Research Institute, Beth Israel Deaconess Cancer Center, Boston, MA, USA. yheng@bidmc.harvard.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Jun</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ahearn</LastName>                    <ForeName>Thomas U</ForeName>                    <Initials>TU</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Brown</LastName>                    <ForeName>Susan B</ForeName>                    <Initials>SB</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Xuehong</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Channing Division of Network Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ambrosone</LastName>                    <ForeName>Christine B</ForeName>                    <Initials>CB</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>de Andrade</LastName>                    <ForeName>Victor Piana</ForeName>                    <Initials>VP</Initials>                    <AffiliationInfo>                        <Affiliation>Departamento de Patologia, AC Camargo Cancer Center, São Paulo, Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Brufsky</LastName>                    <ForeName>Adam M</ForeName>                    <Initials>AM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Couch</LastName>                    <ForeName>Fergus J</ForeName>                    <Initials>FJ</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>King</LastName>                    <ForeName>Tari A</ForeName>                    <Initials>TA</Initials>                    <AffiliationInfo>                        <Affiliation>Dana-Farber Cancer Institute and Brigham and Women's Cancer Center, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Modugno</LastName>                    <ForeName>Francesmary</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Vachon</LastName>                    <ForeName>Celine M</ForeName>                    <Initials>CM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>DuPre</LastName>                    <ForeName>Natalie C</ForeName>                    <Initials>NC</Initials>                    <AffiliationInfo>                        <Affiliation>Channing Division of Network Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Garcia-Closas</LastName>                    <ForeName>Montserrat</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Troester</LastName>                    <ForeName>Melissa A</ForeName>                    <Initials>MA</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hunter</LastName>                    <ForeName>David J</ForeName>                    <Initials>DJ</Initials>                    <AffiliationInfo>                        <Affiliation>Channing Division of Network Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Nuffield Department of Population Health, University of Oxford, Oxford, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Eliassen</LastName>                    <ForeName>A Heather</ForeName>                    <Initials>AH</Initials>                    <AffiliationInfo>                        <Affiliation>Channing Division of Network Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tamimi</LastName>                    <ForeName>Rulla M</ForeName>                    <Initials>RM</Initials>                    <AffiliationInfo>                        <Affiliation>Channing Division of Network Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hankinson</LastName>                    <ForeName>Susan E</ForeName>                    <Initials>SE</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Channing Division of Network Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Beck</LastName>                    <ForeName>Andrew H</ForeName>                    <Initials>AH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Dana 517B, Boston, MA, 02215, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Cancer Research Institute, Beth Israel Deaconess Cancer Center, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>P01CA87969</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>UM1CA186107</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>UM1 CA176726</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>R01CA166666</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>SAC110014</GrantID>                    <Agency>Susan G. Komen</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>UM1CA176726</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>U19CA148065</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>CCR14302670</GrantID>                    <Agency>Susan G. Komen</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>11</Month>                <Day>01</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Breast Cancer Res Treat</MedlineTA>            <NlmUniqueID>8111104</NlmUniqueID>            <ISSNLinking>0167-6806</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Gene expression</Keyword>            <Keyword MajorTopicYN="N">Nurses’ health study</Keyword>            <Keyword MajorTopicYN="N">Obesity</Keyword>            <Keyword MajorTopicYN="N">Polish breast cancer study</Keyword>            <Keyword MajorTopicYN="N">The cancer genome atlas</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>07</Month>                <Day>27</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>29</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30387004</ArticleId>            <ArticleId IdType="doi">10.1007/s10549-018-5034-1</ArticleId>            <ArticleId IdType="pii">10.1007/s10549-018-5034-1</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>